Attenuation of cytotoxic natural product DNA intercalating agents by caffeine

29Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

Many anti-tumor drugs function by intercalating into DNA. The xanthine alkaloid caffeine can also intercalate into DNA as well as form π-π molecular complexes with other planar alkaloids and anti-tumor drugs. The presence of caffeine could interfere with the intercalating anti-tumor drug by forming π-π molecular complexes with the drug, thereby blocking the planar aromatic drugs from intercalating into the DNA and ultimately lowering the toxicity of the drug to the cancer cells. The cytotoxic activities of several known DNA intercalators (berberine, camptothecin, chelerythrine, doxorubicin, ellipticine, and sanguinar-ine) on MCF-7 breast cancer cells, both with and without caffeine present (200 μg/mL) were determined. Significant attenuation of the cytotoxicities by caffeine was found. Computational molecular modeling studies involving the intercalating anti-tumor drugs with caffeine were also carried out using density functional theory (DFT) and the recently developed M06 functional. Relatively strong π-π interaction energies between caffeine and the intercalators were found, suggesting an "interceptor" role of caffeine protecting the DNA from intercalation. © Srinivasa Rao et al.

Cite

CITATION STYLE

APA

Hill, G. M., Moriarity, D. M., & Setzer, W. N. (2011). Attenuation of cytotoxic natural product DNA intercalating agents by caffeine. Scientia Pharmaceutica, 79(4), 729–747. https://doi.org/10.3797/scipharm.1107-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free